4//SEC Filing
Hoenlein Malcolm 4
Accession 0001104659-20-033109
CIK 0001429260other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:06 PM ET
Size
5.3 KB
Accession
0001104659-20-033109
Insider Transaction Report
Form 4
Hoenlein Malcolm
Director
Transactions
- Award
Common Stock
2020-01-01+50,000→ 385,000 total
Footnotes (2)
- [F1]One-third of the shares will vest on each January 1, 2021, 2022 and 2023, subject to continued service. The reporting person elected to defer 100% of these restricted shares pursuant to the issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the reporting person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the issuer.
- [F2]The total holdings include 250,000 shares underlying deferred restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001294517
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:06 PM ET
- Size
- 5.3 KB